-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Anbio Biotechnology quarterly Liabilities, Current history and change rate from Q4 2023 to Q4 2024.
- Anbio Biotechnology Liabilities, Current for the quarter ending 31 Dec 2024 was $1.73M, a 74.2% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)